On 30 September 2021, ISDA submitted a response to the European Securities and Markets Authority’s (ESMA) Consultation Paper on the Guidelines on reporting under EMIR. Two response documents were submitted: one provides responses to the questions put forward by ESMA and the second document provides comments on the validation and reconciliation rules. In the response, ISDA highlighted a several points including:
- The application of field reconciliation and tolerance levels
- The use of UPIs and related reference data
- The format of TR reports
- ETDs being reported as OTC derivatives when executed on third country markets
ESMA intend to publish a final report on the EMIR reporting guidance in the first quarter of 2022 based on the response received for this consultation.
Documents (2) for ISDA Responds to the ESMA Consultation Paper on the Guidelines on Reporting under EMIR
Latest
Building Markets, Creating Opportunity
Deep and liquid derivatives markets are fundamental to the development of well-functioning financial markets and healthy economies. They support lending, investment and financial stability, creating the certainty needed for economic growth. But strong derivatives markets do not emerge by chance....
Key Trends in OTC Derivatives Market H2 2025
The latest data from the Bank for International Settlements over-the-counter (OTC) derivatives statistics shows an increase in notional outstanding of OTC derivatives during the second half of 2025 compared to the same period in 2024. Notional outstanding rose across all...
ISDA-SIFMA letter to SEC on Swap Dealer Thresholds
ISDA and SIFMA have submitted a comment letter to the SEC in response to the staff report on the definitions of “security-based swap dealer” and “major security-based swap participant.” The associations recommend maintaining the current de minimis thresholds for both...
ISDA responds to RBI consultation on SA-CCR
On July 1, ISDA responded to the Reserve Bank of India's (RBI) consultation on draft amendment directions on the standardized approach for counterparty credit risk (SA-CCR). ISDA broadly welcomes the RBI's move to SA-CCR and updated capital treatment for exposures...